Literature DB >> 2221135

A method for continual monitoring of bone resorption in rats: evidence for a diurnal rhythm.

R C Mühlbauer1, H Fleisch.   

Abstract

A method has been developed to monitor bone resorption (BR) based on the urinary excretion of [3H]tetracycline ([3H]TC) from chronically prelabeled rats. This is possible because the [3H]TC released from bone has been found to be in a form that is not or only poorly bound to apatite and thus not reincorporated into newly formed bone. When BR was increased by means of dietary calcium restriction, parathyroid hormone (PTH) infusion, or retinoid injections, urinary [3H]TC doubled. When BR was inhibited by feeding calcium supplements or administration of dichloromethylenebisphosphonate, [3H]TC excretion dropped by two-thirds. Thyroparathyroidectomy inhibited [3H]TC excretion by one-third. The results obtained with this technique are therefore similar to those obtained with other methods such as 45Ca kinetics. The effect of dietary manipulations on BR was detected within 6 h of changing diet. Furthermore, a strong diet-dependent but PTH- and calcitonin-independent diurnal rhythm in BR was found. By use of this technique, bone resorption can be assessed continuously over long periods, and the acute regulation of bone resorption can be studied for the first time.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2221135     DOI: 10.1152/ajpregu.1990.259.4.R679

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

1.  Inflammation-mediated osteopenia (IMO): no change in bone resorption during its development.

Authors:  U G Lempert; H W Minne; H Fleisch; R C Mühlbauer; S H Scharla; R Ziegler
Journal:  Calcif Tissue Int       Date:  1991-04       Impact factor: 4.333

2.  H-tetracycline as a proxy for Ca for measuring dietary perturbations of bone resorption.

Authors:  Connie Weaver; Jennifer Cheong; George Jackson; David Elmore; George McCabe; Berdine Martin
Journal:  Nucl Instrum Methods Phys Res B       Date:  2007       Impact factor: 1.377

Review 3.  Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease.

Authors:  H Fleisch
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

4.  [Supportive drugs for improved implant healing].

Authors:  R Skripitz; A Kurth; A Roth
Journal:  Orthopade       Date:  2015-09       Impact factor: 1.087

5.  Bone-seeking labels as markers for bone turnover: validation of urinary excretion in rats.

Authors:  J M K Cheong; N S Gunaratna; G P McCabe; G S Jackson; A Kempa-Steczko; C M Weaver
Journal:  Osteoporos Int       Date:  2010-05-18       Impact factor: 4.507

6.  Ovariectomy in the rat induces a rapid increase in the urinary excretion of hydroxylysine glycosides and non-reducible crosslink residues.

Authors:  E Casari; M Alfano; M Valente; G D Clarke; G Ferni; B Grazioli
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

7.  The diurnal rhythm of bone resorption in the rat. Effect of feeding habits and pharmacological inhibitors.

Authors:  R C Mühlbauer; H Fleisch
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Validation of urinary calcium isotope excretion from bone for screening anabolic therapies for osteoporosis.

Authors:  E E Hohman; G P McCabe; M Peacock; C M Weaver
Journal:  Osteoporos Int       Date:  2014-06-27       Impact factor: 4.507

Review 9.  Bone as an effect compartment : models for uptake and release of drugs.

Authors:  David Stepensky; Lilach Kleinberg; Amnon Hoffman
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

10.  Measurement of serum [3H]tetracycline kinetics and indices of kidney function facilitate study of the activity and toxic effects of bisphosphonates in bone resorption.

Authors:  G Golomb; Y Eitan; A Hoffman
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.